Article Details
Retrieved on: 2024-12-10 21:36:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
- Q32 Bio Inc. (NASDAQ: QTTB), a biotechnology firm specializing in immune system therapeutics, has announced plans to progress its drug candidate ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here